Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 583-593

  Pant, Neha ^a   Marcotte, Harold ^a   Hermans, Pim ^b   Bezemer, Sandra ^b   Frenken, Leon ^c   Johansen, Kari ^d   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BAC BV   (Netherlands)

^c UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

antibodies n diarrhea; lactobacilli; passive immunization; rotavirus

Indexed keywords

ANTI ROTAVIRUS PROTEIN; ANTI ROTAVIRUS PROTEIN 1; ANTI ROTAVIRUS PROTEIN 3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIODACTYLA; BINDING AFFINITY; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; INFECTIOUS DIARRHEA; LACTOBACILLUS; LACTOBACILLUS PARACASEI; LLAMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, BISPECIFIC; CAMELIDS, NEW WORLD; DIARRHEA; IMMUNIZATION, PASSIVE; LACTOBACILLUS; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS;

ANIMALIA; LACTOBACILLUS PARACASEI; LAMA (MAMMAL); ROTAVIRUS;

EID: 79956146838     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.32     Document Type: Article

References (29)

1. Parashar UD, Burton A, Lanata C et al.: Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis. 200(Suppl. 1) S9-S15 (2009).
2. Martinelli D, Prato R, Chironna M et al.: Large outbreak of viral gastroenteritis caused by contaminated drinking water in Apulia, Italy, May-October 2006. Euro Surveill. 12(4), E070419.1 (2007).
3. Pant N, Marcotte H, Bruessow H, Svensson L, Hammarström L: Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol. 7, 86 (2007).
4. Sarker SA, Casswall TH, Mahalanabis D et al.: Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr. Infect. Dis. J. 17(12), 1149-1154 (1998). (Pubitemid 29023892)
5. Hamers-Casterman C, Atarhouch T, Muyldermans S et al.: Naturally occurring antibodies devoid of light chains. Nature 363(6428), 446-448 (1993). (Pubitemid 23179389)
6. Frenken LG, van der Linden RH, Hermans PW et al.: Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J. Biotechnol. 78(1), 11-21 (2000). (Pubitemid 30084786)
7. Stijlemans B, Conrath K, Cortez-Retamozo V et al.: Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 279(2), 1256-1261 (2004). (Pubitemid 38082649)
8. De Genst E, Silence K, Decanniere K et al.: Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl Acad. Sci. USA 103(12), 4586-4591 (2006).
9. Lauwereys M, Arbabi Ghahroudi M, Desmyter A et al.: Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17(13), 3512-3520 (1998). • Describes how the small size and structure of VHH make them able to recognize nonconventional epitopes that are cryptic for conventional antibodies. (Pubitemid 28327370)
10. Conrath KE, Lauwereys M, Wyns L, Muyldermans S: Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276(10), 7346-7350 (2001).
11. Saerens D, Ghassabeh GH, Muyldermans S: Single-domain antibodies as building blocks for novel therapeutics. Curr. Opin. Pharmacol. 8(5), 600-608 (2008)
12. Coppieters K, Dreier T, Silence K et al.: Formatted anti-tumor necrosis factor a VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 54(6), 1856-1866 (2006). (Pubitemid 43877935)
13. Harmsen MM, Fijten HPD, Engel B, Dekker A, Eblé PL: Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin. Vet. Microbiol. 132(1-2), 56-64 (2008).
14. Garaicoechea L, Olichon A, Marcoppido G et al.: Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J. Virol. 82(19), 9753-9764 (2008). • The first description of the generation of a VHH antibody fragment against VP6 that has a broad neutralizing activity against rotavirus.
15. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF: Probiotics for treating infectious diarrhoea. Cochrane Database Syst. Rev. 2, CD003048 (2004).
16. Pant N, Hultberg A, Zhao Y et al.: Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J. Infect. Dis. 194(11), 1580-1588 (2006). • Shows, for the first time, the possibility of expressing VHH antibody fragment genes in lactobacilli and their use for the treatment of rotavirus-induced diarrhea in a mouse model. (Pubitemid 44851901)
17. Marcotte H, Pant N, Hammarström L: Engineered lactobody-producing lactobacilli: A novel form of therapy against rotavirus infection. Future Virol. 3(4), 327-341 (2008). • Review describing the concept of using lactobacilli producing VHH fragments for passive immunization against rotavirus.
18. Stucker G, Oshiro L, Schmidt NJ: Antigenic comparisons of two new rotaviruses from rhesus monkeys. J. Clin. Microbiol. 11(2), 202-203 (1980). (Pubitemid 10169145)
19. van der Vaart JM, Pant N, Wolvers D et al.: Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 24(19), 4130-4137 (2006). • Key paper describing the generation of protective VHH antibody fragments against rotavirus that were used in this paper. (Pubitemid 44308223)
20. Martín MC, Pant N, Ladero V et al.: Integrative expression system for delivery of antibody fragments by lactobacilli. Appl. Env. Microbiol. 77(6), 2174-2179 (2011). • Description of the plasmid expression system used in this paper.
21. Acedo-Felix E, Perez-Martinez G: Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study. Int. J. Syst. Evol. Microbiol. 53(Pt 1), 67-75 (2003). (Pubitemid 36285222)
22. Krüger C, Hu Y, Pan Q et al.: In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol. 20(7), 702-706 (2002). (Pubitemid 34734137)
23. Offit PA, Clark HF, Kornstein MJ, Plotkin SA: A murine model for oral infection with a primate rotavirus (simian SA11). J. Virol. 51(1), 233-236 (1984). (Pubitemid 14081260)
24. Dennehy PH: Rotavirus vaccines: An overview. Clin. Microbiol Rev. 21(1), 198-208 (2008). (Pubitemid 351160015)
25. Estes M, Kapikian A: Rotaviruses. In:Fields Virology (5th Edition). Knipe DM, Howley PM, Griffin DE et al. (Eds). Kluwer/Lippincott, Williams and Wilkins, PA, USA 1917-1974 (2007).
26. Pai JC, Sutherland JN, Maynard JA: Progress towards recombinant anti-infective antibodies. Recent Patents Anti-Infect. Drug Disc. 4(1), 1-17 (2009).
27. Dormitzer PR, Nason EB, Prasad BV, Harrison SC: Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature 430 (7003), 1053-1058 (2004). (Pubitemid 39136201)
28. de Kruif J, Kramer A, Nijhuis R et al.: Generation of stable cell clones expressing mixtures of human antibodies. Biotechnol. Bioeng. 106(5), 741-750 (2010).
29. Hmila I, Abdallah RBA, Saerens D et al.: VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. Mol. Immunol. 45(14), 3847-3856 (2008).